Canandaigua National Corp’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$448K Buy
+1,517
New +$451K 0.04% 245
2022
Q4
$367K Sell
2,182
-24
-1% -$4.17K 0.06% 187
2022
Q3
$391K Buy
2,206
+4
+0.2% +$791 0.07% 183
2022
Q2
$451K Buy
2,202
+4
+0.2% +$848 0.08% 175
2022
Q1
$523K Buy
2,198
+8
+0.4% +$1.88K 0.08% 179
2021
Q4
$500K Buy
2,190
+44
+2% +$9.68K 0.07% 183
2021
Q3
$415K Hold
2,146
0.07% 186
2021
Q2
$456K Sell
2,146
-5
-0.2% -$1.06K 0.07% 178
2021
Q1
$439K Buy
2,151
+16
+0.7% +$3.15K 0.07% 178
2020
Q4
$389K Hold
2,135
0.07% 182
2020
Q3
$357K Sell
2,135
-90
-4% -$15.2K 0.06% 184
2020
Q2
$362K Buy
+2,225
New +$399K 0.07% 180

Other funds holding CME

Canandaigua National Corp's CME Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in CME Group (CME) in Q1 2026: 1,517 shares worth $448K. The stake represents 0.04% of the portfolio and ranks #245 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in CME as recently as Q4 2022.

Canandaigua National Corp first reported a position in CME in Q2 2020 and has held it in 12 quarters since. The position peaked at $523K in Q1 2022. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Canandaigua National Corp held 1,517 shares of CME Group worth $448K as of Q1 2026.
  • CME Group was a new Canandaigua National Corp position in Q1 2026.
  • CME Group made up 0.04% of Canandaigua National Corp's portfolio in Q1 2026, its #245 holding.
  • Canandaigua National Corp first reported a position in CME Group in Q2 2020 and has held it in 12 quarters since.
  • Canandaigua National Corp's CME Group position peaked at $523K in Q1 2022.
  • 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.